Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.3100 (-2.46%) ($8.2900 - $8.3100) on Mon. Jun. 12, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.72% (three month average) | RSI | 46 | Latest Price | $8.3100(-2.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.2% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) SDY(26%) BND(25%) XLRE(25%) VYM(23%) ARKG(22%) | Factors Impacting BCRX price | BCRX will decline at least -1.36% in a week (0% probabilities). VIXM(-26%) VXX(-23%) TLT(-18%) VCIT(-17%) SHY(-17%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.36% (StdDev 2.72%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $8.42 | 5 Day Moving Average | $8.6(-3.37%) | 10 Day Moving Average | $8.44(-1.54%) | 20 Day Moving Average | $8.42(-1.31%) | To recent high | -6.2% | To recent low | 12.7% | Market Cap | $1.466b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |